Sonja Nodland received her Masters degree in Cellular and Molecular Biology from Washington University in St. Louis and Doctorate in Immunology and Cancer Biology from the University of Minnesota. After completing a post doctoral fellowship in human developmental immunology in Tucker LeBien’s laboratory at the University of Minnesota she became a scientist in the Healthcare division of Biothera Inc., working with the functional food and beverage ingredient, Wellmune®. During her time at Biothera she was responsible for the development and implementation of the research program to identify immune biomarkers of Wellmune’s function. After the Wellmune business was acquired by Kerry in 2015, she took on responsibilities for the clinical research program for Wellmune. Since the acquisition of Ganeden BC30 by Kerry in September 2017, Sonja is active in technical support and clinical study development to support the efficacy of the Ganeden BC30 ingredient in addition to the Wellmune research portfolio. In her spare time Sonja enjoys spending time with family and friends, reading, volunteering in her community, golfing and playing music.